Cargando…
A Look Into the Next Century After 100 Years of Insulin
Being diagnosed with diabetes can be challenging, particularly if we do not know a similar individual with the same disease. A person's life may suddenly change and he/she may not be aware of the possibilities or treatment options available or the questions that need to be asked; hence, instead...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645298/ https://www.ncbi.nlm.nih.gov/pubmed/36381916 http://dx.doi.org/10.7759/cureus.30133 |
_version_ | 1784826935909548032 |
---|---|
author | Gupta, Sonal Acharya, Sourya Shukla, Samarth |
author_facet | Gupta, Sonal Acharya, Sourya Shukla, Samarth |
author_sort | Gupta, Sonal |
collection | PubMed |
description | Being diagnosed with diabetes can be challenging, particularly if we do not know a similar individual with the same disease. A person's life may suddenly change and he/she may not be aware of the possibilities or treatment options available or the questions that need to be asked; hence, instead of looking for assistance, many people hide their diabetic condition from others. But due to innovative devices, individuals no longer need to be concerned. Various gadgets today help provision insulin via a subcutaneous route, for example, an insulin pen, pump, vial, or syringe. Despite being the most familiar way to provide insulin, subcutaneous insulin delivery is linked to needle pain, injection anxiety, lipodystrophy, compliance issues, and peripheral hyperinsulinemia; thus, there is a need for an insulin delivery system that is both less invasive and more biological. The discovery of insulin and its uses are linked to the beginning of diabetes treatment. Initially, the delivery of insulin was accomplished using giant, heavy, reusable syringes equipped with plungers, barrels, and wide-bore needles. To prepare these syringes and needles for reuse, these were boiled. The development of insulin syringes, which are presently in use and have revolutionized healthcare, resulted from manufacturers' continued efforts and technological innovations. Injections of insulin may become obsolete if research from the University of Alberta is successful. Researchers from the University of Alberta claim that insulin-producing cells developed from stem cells are secure for transplantation to wean diabetes patients from injectable insulin permanently. In a significant mice experiment, experts demonstrated the role of the inceptor (insulin inhibitory receptor), which protects the beta cells from insulin pathway activation. Insulin resistance in diabetes may be exacerbated by the inceptor's ability to block insulin signaling. Technologies known as "smart insulin" (glucose-responsive insulin) deliver insulin according to the patient's glycemic condition without needing additional monitoring by the patient or the physician in charge. The review of insulin administration devices and several cutting-edge insulin-related ideas are the main topics of this article. |
format | Online Article Text |
id | pubmed-9645298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-96452982022-11-14 A Look Into the Next Century After 100 Years of Insulin Gupta, Sonal Acharya, Sourya Shukla, Samarth Cureus Endocrinology/Diabetes/Metabolism Being diagnosed with diabetes can be challenging, particularly if we do not know a similar individual with the same disease. A person's life may suddenly change and he/she may not be aware of the possibilities or treatment options available or the questions that need to be asked; hence, instead of looking for assistance, many people hide their diabetic condition from others. But due to innovative devices, individuals no longer need to be concerned. Various gadgets today help provision insulin via a subcutaneous route, for example, an insulin pen, pump, vial, or syringe. Despite being the most familiar way to provide insulin, subcutaneous insulin delivery is linked to needle pain, injection anxiety, lipodystrophy, compliance issues, and peripheral hyperinsulinemia; thus, there is a need for an insulin delivery system that is both less invasive and more biological. The discovery of insulin and its uses are linked to the beginning of diabetes treatment. Initially, the delivery of insulin was accomplished using giant, heavy, reusable syringes equipped with plungers, barrels, and wide-bore needles. To prepare these syringes and needles for reuse, these were boiled. The development of insulin syringes, which are presently in use and have revolutionized healthcare, resulted from manufacturers' continued efforts and technological innovations. Injections of insulin may become obsolete if research from the University of Alberta is successful. Researchers from the University of Alberta claim that insulin-producing cells developed from stem cells are secure for transplantation to wean diabetes patients from injectable insulin permanently. In a significant mice experiment, experts demonstrated the role of the inceptor (insulin inhibitory receptor), which protects the beta cells from insulin pathway activation. Insulin resistance in diabetes may be exacerbated by the inceptor's ability to block insulin signaling. Technologies known as "smart insulin" (glucose-responsive insulin) deliver insulin according to the patient's glycemic condition without needing additional monitoring by the patient or the physician in charge. The review of insulin administration devices and several cutting-edge insulin-related ideas are the main topics of this article. Cureus 2022-10-10 /pmc/articles/PMC9645298/ /pubmed/36381916 http://dx.doi.org/10.7759/cureus.30133 Text en Copyright © 2022, Gupta et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Gupta, Sonal Acharya, Sourya Shukla, Samarth A Look Into the Next Century After 100 Years of Insulin |
title | A Look Into the Next Century After 100 Years of Insulin |
title_full | A Look Into the Next Century After 100 Years of Insulin |
title_fullStr | A Look Into the Next Century After 100 Years of Insulin |
title_full_unstemmed | A Look Into the Next Century After 100 Years of Insulin |
title_short | A Look Into the Next Century After 100 Years of Insulin |
title_sort | look into the next century after 100 years of insulin |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645298/ https://www.ncbi.nlm.nih.gov/pubmed/36381916 http://dx.doi.org/10.7759/cureus.30133 |
work_keys_str_mv | AT guptasonal alookintothenextcenturyafter100yearsofinsulin AT acharyasourya alookintothenextcenturyafter100yearsofinsulin AT shuklasamarth alookintothenextcenturyafter100yearsofinsulin AT guptasonal lookintothenextcenturyafter100yearsofinsulin AT acharyasourya lookintothenextcenturyafter100yearsofinsulin AT shuklasamarth lookintothenextcenturyafter100yearsofinsulin |